financetom
Business
financetom
/
Business
/
Manulife Financial Q1 Core Earnings Rise, Declares Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Manulife Financial Q1 Core Earnings Rise, Declares Dividend
May 8, 2024 2:44 PM

05:21 PM EDT, 05/08/2024 (MT Newswires) -- Manulife Financial ( MFC ) reported Q1 core earnings late Wednesday of CA$0.94 ($0.68) per diluted share, up from CA$0.79 per share a year earlier.

Analysts polled by Capital IQ expected CA$0.91.

Separately, the company's board kept its quarterly dividend at CA$0.40 per share, payable June 19 to shareholders of record at the close of business on May 22.

Price: 24.35, Change: -0.12, Percent Change: -0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Disney-backed A+E Global Media Renews Ad Tech Partnership With Comcast's FreeWheel
Disney-backed A+E Global Media Renews Ad Tech Partnership With Comcast's FreeWheel
Mar 20, 2025
08:50 AM EDT, 03/20/2025 (MT Newswires) -- Walt Disney ( DIS )-backed (DIS) A+E Global Media said Thursday that it has renewed its partnership with Comcast's ( CMCSA ) FreeWheel for its advertising business. Financial terms were not disclosed. A+E said the key to the renewal is its ability to use FreeWheel's audience manager utility to enable advertisers to deliver...
Temu Parent PDD Fourth-Quarter Revenue Misses Street Views
Temu Parent PDD Fourth-Quarter Revenue Misses Street Views
Mar 20, 2025
08:51 AM EDT, 03/20/2025 (MT Newswires) -- PDD Holdings ( PDD ) on Thursday reported fourth-quarter results that rose year over year but the Chinese e-commerce platform's revenue fell short of market expectations. Adjusted earnings advanced to 20.15 renminbi ($2.76) per American depositary share in the December quarter from 17.32 renminbi a year earlier, ahead of the FactSet-polled consensus of...
BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer
BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer
Mar 20, 2025
08:46 AM EDT, 03/20/2025 (MT Newswires) -- BriaCell Therapeutics ( BCTX ) announced Thursday that an external data safety monitoring board has completed its second safety data review and recommended that the company continue without any modifications its current pivotal phase 3 trial of Bria-IMT plus an immune checkpoint inhibitor in metastatic breast cancer. The company added that it is...
Windtree Signs Deal to Become Sourcing Partner for Evofem's Contraceptive Vaginal Gel; Shares Rise
Windtree Signs Deal to Become Sourcing Partner for Evofem's Contraceptive Vaginal Gel; Shares Rise
Mar 20, 2025
08:49 AM EDT, 03/20/2025 (MT Newswires) -- Windtree Therapeutics ( WINT ) said Thursday it signed a license and supply agreement to become the sourcing partner for Evofem Biosciences' Phexxi, an on-demand prescription contraceptive vaginal gel. Under the deal, Windtree will contract with the manufacturer to produce Phexxi at a cost lower than current levels, the company said. Evofem will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved